Professor at UT Southwestern Medical Center, Study hypoxia, oxygen sensing pathway and VHL pathway in cancers, including breast and kidney cancers.
Dallas,TX
Joined May 2009
- Tweets2.6K
- Following1.3K
- Followers2.4K
- Likes11.3K
Qing Zhang retweeted
Online Now: PHYHD1-mediated translational control regulates renal cell carcinoma progression dlvr.it/TVtQhR
PHYHD1-mediated translational control regulates renal cell carcinoma progression: Molecular Cell cell.com/molecular-cell/full…
Happy to share our latest study @MolecularCell on identifying PHYHD1 as a potent tumor suppressor in renal cancer by regulating protein translation. Thanks for the support from @utswcancer @UTSW_Pathology @JBrugarolas @KCPUTSW @ChenghengLiao @zhou_jian and many others
Development of A10P3C, an isoform-selective inhibitor of EGLN2, for targeting breast cancer | PNAS pnas.org/doi/10.1073/pnas.26…
Glad to share our latest publication @PNASNews on the development of EglN2 prolyl hydroxylase specific inhibitor in breast cancer. We appreciate the generous supports from @UTSWMedCenter @utswcancer @UTSW_Pathology on this study.
Thanks for posting. @utswcancer @UTSW_Pathology
From Texas to Germany! 🌍 Today, Qing Zhang, M.D., UTSW Director of Investigative Pathology & CSO of our Breast Cancer Research Program, presented “Targeting Oxygen-Sensing Signaling in Cancer” at the HYPOX EU Forum in Essen, Germany.
#CancerResearch #UTSW #Hypoxia
ALT A person stands at a podium giving a presentation with a banner that says "Welcome to HypoxEU" in the background. Several water bottles are placed on a side table. The banner includes the tagline "Where researchers connect & discover."
Qing Zhang retweeted
From Texas to Germany! 🌍 Today, Qing Zhang, M.D., UTSW Director of Investigative Pathology & CSO of our Breast Cancer Research Program, presented “Targeting Oxygen-Sensing Signaling in Cancer” at the HYPOX EU Forum in Essen, Germany.
#CancerResearch #UTSW #Hypoxia
ALT A person stands at a podium giving a presentation with a banner that says "Welcome to HypoxEU" in the background. Several water bottles are placed on a side table. The banner includes the tagline "Where researchers connect & discover."
Qing Zhang retweeted
🙌Hey @utswcancer @UTSWMedCenter @UTSWCancerBio @UTSWHemeOnc @UTSWScience @UTSW_Pathology @UTSWMolBiol don't miss the next #KomenBreastCancerForum feat. Dr. Min Yu @UMmedschool. #CirculatingTumorCells #Metastasis
Qing Zhang retweeted
📣 Call for Abstracts is OPEN! DEADLINE AUGUST 28, 2026 #IKCSNA26
Join us for the 2026 International Kidney Cancer Symposium (IKCS): North America
buff.ly/Wjo6fH1
IKCS: North America brings together a dynamic, multidisciplinary community of leading experts across academia, clinical care, industry, and advocacy to share innovative ideas, explore emerging trends, and shape the future of kidney cancer research and care.
🗓️ Date: November 19–21, 2026
📍 Location: Dallas, Texas
🏨 Meeting Hotel: Renaissance Dallas Hotel
Have groundbreaking research to share? Submit your abstract and join the conversation that is advancing kidney cancer care.
🔗 Call for Abstracts: November 19–21
@KidneyCancer
@LauraBukavinaMD
@QingZhangLab
@bergsa83
@mkbupathi
@ADESAIONCMD
@AmyLuckenbaugh
@virajmaster
@spsutkaMD
@ChadTangMD
@MVossMD
@TiansterZhang
@PavlosMsaouel
@salvolarosa
@GEVaughan1
Qing Zhang retweeted
🎉 Registration for our 2026 International Kidney Cancer Symposium (IKCS): North America is open! #IKCSNA26
Early registration rates available now. We're excited to welcome you to Dallas!
Reserve your spot to join us 👉 web.cvent.com/event/885b2adb…
Qing Zhang retweeted
#KCRS26 starts TOMORROW!
Tomorrow, researchers, clinicians, industry leaders, and advocates from around the world will come together for two days of groundbreaking science and meaningful discussion focused on advancing #KidneyCancer research.
We can't wait to see everyone there!
#AcceleratingCures
Qing Zhang retweeted
Boston-bound for KCRS26. ✈️ Two days that pack the entire kidney cancer field, bench to bedside, into one room. So many brilliant minds in the room: @AlbigesL @HHammersMD @EJonasch @DrChoueiri @DrRanaMcKay @montypal @MikeSerzanMD @QingZhangLab @JBrugarolas @tompowles1 @DrKarieRuncie @YuWeiChenMD @paulosiqamaral @BraunMDPhD @KotechaMD @PavlosMsaouel @TiansterZhang and more that i've missed!
On Friday I am giving the ASCO GU highlights, so I have been living in the RCC data. A few things showing up in the program overall:
🎯 HIF-2α inhibitors moving earlier in the disease
🔬 PSMA showing up as a target outside prostate
🤖 AI creeping into the diagnostic workflow
KidneyCAN took dedicated federal funding for kidney cancer research from $0 in 2016 to more than $285M, and is still fighting for it on the Hill. 🙏
Full program 📄 bit.ly/kcrs26-program
More as the sessions run. If you are here, come find me. 🧬
#KidneyCancer #RCC #GUonc #KCRS26
Qing Zhang retweeted
The #KCRS26 Abstract Book is now available!
Get an early look at the innovative research that will be presented during this year's Kidney Cancer Research Summit. From basic and translational science to clinical research, the Abstract Book offers a preview of the discoveries helping shape the future of #KidneyCancer research.
📖 View the Abstract Book: kcrs.kidneycan.org/kcrs26-ab…
Then join us virtually on July 23-24 to hear these findings presented and discussed by the researchers behind the work! kcrs.kidneycan.org
#AcceleratingCures
Qing Zhang retweeted
Chromosome loss is detrimental to cellular fitness, yet can be an early event in cancer. How can a deleterious genomic alteration initiate tumorigenesis? 🤔
Our latest preprint tackles this paradox using clear cell renal cell carcinoma (ccRCC) as a model.
biorxiv.org/content/10.64898…
🙌Hey @utswcancer @UTSWMedCenter @UTSWCancerBio @UTSWHemeOnc @UTSWScience
@UTSW_Pathology @UTSWMolBiol don't miss the next #KomenBreastCancerForum @jaehyukchoimd to present design of next genereation cell therapies @AriellaHanker @CarlosArteagaMD @hmcarthur 6/17 9am IN PERSON
Qing Zhang retweeted
@KCRS26 is shaping up to be another fantastic meeting for the #kidneycancer community. Great science, great conversations, and great people! Hope to see many of you in Boston on July 23–24, or online if you can’t make the trip.
#KCRS26 will bring together leaders in kidney cancer research, clinical care, advocacy, industry, and the patient community.
In-person attendance is limited due to space constraints; however, virtual registration is free and open to all.
Register: bit.ly/KCRS26Registration
#KidneyCancer @kidneycan
Qing Zhang retweeted
The SOCS3/JAK1/STAT3/HIF-2α axis represents a new novel regulatory pathway that integrates cytokine signaling with enhancer-mediated transcriptional control in clear cell renal cell carcinoma (ccRCC): doi.org/10.1172/JCI201639
Qing Zhang retweeted
Offering new targets to overcome treatment resistance in kidney cancer: doi.org/10.1172/JCI201639
Jun Fang @JunFang_UTSW Qing Zhang @QingZhangLab & team @UTSWMedCenter discover that cytokine signaling drives kidney cancer by activating a genetic circuit that boosts HIF-2α expression.
The figure shows SOCS3 induction by DOX suppressed tumor growth, as revealed by longitudinal bioluminescence imaging at week 0 and week 10.
#ccRCC
